| Drug Overdosing:
How to Avoid Medication Side Effects
Updated: 08/16/2004
References
Physicians' Desk Reference.2003 57th Edition .
AMA. AMA Drug Evaluations, Annual 1994. : .1994.
AMA. AMA Drug Evaluations.1994.
American Medical Association Council on Ethical and Judicial Affairs.
Code of Medical Ethics.1999 1998-1999 Edition.
Angell M. Is academic medicine for sale? N Engl J Med. 2000;342(151-68).
Angell MRAS. Prescription for profit. The Washington Post.2001.Jun.20:A27.
Associated Press. Inhaled steroids for asthma cause bone loss, study finds.
San Diego Union-Tribune.2001.Sep.27:A14.
Avorn J. The prescription as final common pathway. Int J Technol Assess
Health Care. 1995;11(3):384-90.
Azarbal BMJSPKCBKS. Adverse cardiovascular events associated with the
use of Viagra.2000.Mar.14 35(Suppl. A 553A554A;).
Bakker-Arkema RG, Best J, Fayyad R, et al. A brief review paper of the
efficacy and safety of atorvastatin in early clinical trials. Atherosclerosis.
1997 May;131(1):17-23.
Beck TM, Ciociola AA, Jones SE, et al. Efficacy of oral ondansetron in
the prevention of emesis in outpatients receiving cyclophosphamide-based
chemotherapy. The Ondansetron Study Group. Ann Intern Med. 1993 Mar 15;118(6):407-13.
Bensen WG, Fiechtner JJ, McMillen JI, et al. Treatment of osteoarthritis
with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled
trial. Mayo Clin Proc. 1999 Nov;74(11):1095-105.
Bodenheimer T. Uneasy alliance--clinical investigators and the pharmaceutical
industry. N Engl J Med. 2000 May 18;342(20):1539-44.
Bottiger LE, Boman G, Eklund G, et al. Oral contraceptives and thromboembolic
disease: effects of lowering oestrogen content. Lancet. 1980 May 24;1(8178):1097-101.
Bowman L. 51% of U.S. adults take 2 pills or more a day, survey reports.
San Diego Union-Tribune.2001.Jan.17:A8.
Brawn LA, Castleden CM. Adverse drug reactions. An overview of special
considerations in the management of the elderly patient. Drug Saf. 1990
Nov;5(6):421-35.
Bristol-Myers Squibb. Briefing Book for the Rx to OTC Switch of Pravachol
(Pravastatin Sodium).2000.Jul.14.
Brooks CD, Schmid FR, Biundo J, et al. Ibuprofen and aspirin in the treatment
of rheumatoid arthritis. A cooperative double-blind trial. Rheumatol Phys
Med. 1970;10:Suppl-63.
Cain JW. Poor response to fluoxetine: underlying depression, serotonergic
overstimulation, or a "therapeutic window"? J Clin Psychiatry.
1992 Aug;53(8):272-7.
Carroll DN, Roth MT. Evidence for the cardioprotective effects of omega-3
Fatty acids. Ann Pharmacother. 2002 Dec;36(12):1950-6.
Chalmers TM. Clinical experience with Ibuprofen in the treatment of rheumatoid
arthritis. Ann Rheum Dis. 1969 Sep;28(5):513-7.
Cheng H, Rogers JD, Sweany AE, et al. Influence of age and gender on the
plasma profiles of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase
inhibitory activity following multiple doses of lovastatin and simvastatin.
Pharm Res. 1992 Dec;9(12):1629-33.
Ciccolunghi SN, Chaudri HA, Schubiger BI, et al. Report on a long-term
tolerability study of up to two years with diclofenac sodium (Voltaren).
Scand J Rheumatol Suppl. 1978;(22):86-96.
Ciccolunghi SN, Chaudri HA, Schubiger BI. The value and results of long-term
studies with diclofenac sodium (Voltarol). Rheumatol Rehabil. 1979;Suppl
2:100-15.
Cilla DD, Jr., Whitfield LR, Gibson DM, et al. Multiple-dose pharmacokinetics,
pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA
reductase, in healthy subjects. Clin Pharmacol Ther. 1996 Dec;60(6):687-95.
Cimons M. Scientists study gender gap in drug responses. Los Angeles Times.1999.Jun.6(A1):89.
Clark WGBDCJAR. Goth's Medical Pharmacology, 1992.1992 Thirteenth Edition.
Clark WGBDCJAR. Goth's Medical Pharmacology.1992 Thirteenth Edition.
Cloud ML, Offen WW, Matsumoto C, et al. Healing and recurrence of active
duodenal ulcer with nizatidine. Clin Pharmacol Ther. 1989 Sep;46(3):310-6.
Cohen JS. The one-size dose does not fit all: look beyond the guidelines
of drug manufacturers. Newsweek. 1999.Dec.6:92.
Cohen JS. Should patients be given an initial low test dose of sildenafil?
Drug Saf. 2000 Jul;23(1):1-9.
Cohen JS. Adverse drug effects, compliance, and initial doses of antihypertensive
drugs recommended by the Joint National Committee vs the Physicians' Desk
Reference. Arch Intern Med. 2001 Mar 26;161(6):880-5.
Cohen MM, Clark L, Armstrong L, et al. Reduction of aspirin-induced fecal
blood loss with low-dose misoprostol tablets in man. Dig Dis Sci. 1985
Jul;30(7):605-11.
Committee on Understanding the Biology of Sex and Gender Differences BoHSP,
Institute of Medicine NAoS. Exploring the Biological Contributions to
Human Health: Does Sex Matter? 2001. .: .2004.
Davidoff F, DeAngelis CD, Drazen JM, et al. Sponsorship, authorship, and
accountability. N Engl J Med. 2001 Sep 13;345(11):825-6.
de Aloysio D, Rovati LC, Giacovelli G, et al. Efficacy on climacteric
symptoms and safety of low dose estradiol transdermal matrix patches.
A randomized, double-blind placebo-controlled study. Arzneimittelforschung.
2000 Mar;50(3):293-300.
Dobrilla G, Barbara L, Bianchi PG, et al. Placebo controlled studies with
ranitidine in duodenal ulcer. Scand J Gastroenterol Suppl. 1981 Jun;69:101-7.
Elliott WJ, Maddy R, Toto R, et al. Hypertension in patients with diabetes.
Overcoming barriers to effective control. Postgrad Med. 2000 Mar;107(3):29-6,
38.
Ettinger B. Personal perspective on low-dosage estrogen therapy for postmenopausal
women. Menopause. 1999;6(3):273-6.
Ettinger B. Personal perspective on low-dosage estrogen therapy for postmenopausal
women. Menopause. 1999;6(3):273-6.
Everitt DE, Avorn J. Drug prescribing for the elderly. Arch Intern Med.
1986 Dec;146(12):2393-6.
FDA. Mevacor OTC. 2000 Jun. Rockville, MD.2004.
Fukano M, Amano S, Sato J, et al. Subacute hepatic failure associated
with a new antidiabetic agent, troglitazone: a case report with autopsy
examination. Hum Pathol. 2000 Feb;31(2):250-3.
Gaist D, Jeppesen U, Andersen M, et al. Statins and risk of polyneuropathy:
a case-control study. Neurology. 2002 May 14;58(9):1333-7.
GAO. Women Sufficiently Represented in New Drug Testing, but FDA Oversight
Needs Improvement.2001.Jul.6 GAO-01-754.
Gibian T. Rational drug therapy in the elderly or how not to poison your
elderly patients. Aust Fam Physician. 1992 Dec;21(12):1755-60.
Gilman AGRTWNASTP. Goodman and Gilman's: The Pharmacological Basis of
Therapeutics .1996.
GISSI-Prevenzione Investigators. Dietary supplementation with omega-3
polyunsaturated fatty acids and vitamin E after myocardial infarction:
results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio
della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354(44755).
Grady D. Too much of a good thing? Doctor challenges drug manual. New
York Times.1999.Oct.12:D12.
Gram LF. Fluoxetine. N Engl J Med. 1994;331(135461).
Greendale GA, Reboussin BA, Hogan P, et al. Symptom relief and side effects
of postmenopausal hormones: results from the Postmenopausal Estrogen/Progestin
Interventions Trial. Obstet Gynecol. 1998 Dec;92(6):982-8.
Greendale GARBAHPBVMSSJSB-CE. Symptom relief and side effects of postmenopausal
hormones: results from the Postmenopausal Estrogen/Progestin Interventions
Trial. Obstet Gynecol. 1998;92(9828.6).
Hall SS. Claritin and Schering-Plough: a prescription for profit. New
York Times.2001.Mar.11.
Hensley S. When doctors go to class, industry often foots the bill. Wall
Street Journal.2002.Dec.4: A1.
Herxheimer A. How much drug in the tablet? Lancet. 1991 Feb 9;337(8737):346-8.
Herxheimer A. How much drug in the tablet?1991. Lancet. 2004 Feb 9; 337(8737):346-8.
Hingorani K. Double-blind crossover trial comparing ibuprofen with flufenamic
acid in rheumatoid arthritis. Rheumatol Phys Med. 1970;10:Suppl-82.
Holt S, Suder A, Weatherall M, et al. Dose-response relation of inhaled
fluticasone propionate in adolescents and adults with asthma: meta-analysis.
BMJ. 2001 Aug 4;323(7307):253-6.
Holt SSAWMCSSPBR. Commentary: Dosage needs systematic and critical review;
Dose-response relation of inhaled fluticasone propionate in adolescents
and adults with asthma: meta-analysis. 2001 Aug 4; . Br Med J. 2001 Aug
4;323:253.-256.
Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting
enzyme inhibitor therapy. A review of the literature and pathophysiology.
Ann Intern Med. 1992 Aug 1;117(3):234-42.
Kirksey DF, Harto-Truax N. Private practice evaluation of the safety and
efficacy of bupropion in depressed outpatients. J Clin Psychiatry. 1983
May;44(5 Pt 2):143-7.
Kritz FL. Mars and Venus and drugs: sex differences create extra risks
for women. Washington Post.2001.Feb.20:17.
Lacey JV, Jr., Mink PJ, Lubin JH, et al. Menopausal hormone replacement
therapy and risk of ovarian cancer. JAMA. 2002 Jul 17;288(3):334-41.
Lasser KE, Allen PD, Woolhandler SJ, et al. Timing of new black box warnings
and withdrawals for prescription medications. JAMA. 2002 May 1;287(17):2215-20.
Lauritsen K, Andersen BN, Laursen LS, et al. Omeprazole 20 mg three days
a week and 10 mg daily in prevention of duodenal ulcer relapse. Double-blind
comparative trial. Gastroenterology. 1991 Mar;100(3):663-9.
Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions
in hospitalized patients: a meta-analysis of prospective studies. JAMA.
1998 Apr 15;279(15):1200-5.
Leitersdorf E. Gender-related response to fluvastatin in patients with
heterozygous familial hypercholesterolaemia. Drugs. 1994;47 Suppl 2:54-8.
Lewis CE. Characteristics and treatment of hypertension in women: a review
of the literature. Am J Med Sci. 1996 Apr;311(4):193-9.
Louie AK, Lewis TB, Lannon RA. Use of low-dose fluoxetine in major depression
and panic disorder. J Clin Psychiatry. 1993 Nov;54(11):435-8.
Lundblad JKS. The rise and fall of the killer drug Rezulin. LA Times.2000.
Marks L. "Not just a statistic": the history of USA and UK policy
over thrombotic disease and the oral contraceptive pill, 1960s-1970s.
Soc Sci Med. 1999 Nov;49(9):1139-55.
Martin EW. Hazards of Medication: A Manual on Drug Interactions, Contraindications,
and Adverse Reactions with Other Prescribing and Drug Information.1978
Second Edition.
Matalka MS, Ravnan MC, Deedwania PC. Is alternate daily dose of atorvastatin
effective in treating patients with hyperlipidemia? The Alternate Day
Versus Daily Dosing of Atorvastatin Study (ADDAS). Am Heart J. 2002 Oct;144(4):674-7.
McCue RE. Using tricyclic antidepressants in the elderly. Clin Geriatr
Med. 1992 May;8(2):323-34.
McNagny SE. Prescribing hormone replacement therapy for menopausal symptoms.
Ann Intern Med. 1999 Oct 19;131(8):605-16.
Melmon KLMHFHBBNDW. .Melmon and Morrelli's Clinical Pharmacology: Basic
Principles in Therapeutics.1993 Third Edition:- McGraw-Hill.
Mendels J, Johnston R, Mattes J, et al. Efficacy and safety of b.i.d.
doses of venlafaxine in a dose-response study. Psychopharmacol Bull. 1993;29(2):169-74.
Merlotti L, Roehrs T, Koshorek G, et al. The dose effects of zolpidem
on the sleep of healthy normals. J Clin Psychopharmacol. 1989 Feb;9(1):9-14.
Montamat SC, Cusack BJ, Vestal RE. Management of drug therapy in the elderly.
N Engl J Med. 1989 Aug 3;321(5):303-9.
Moore TJ, Psaty BM, Furberg CD. Time to act on drug safety. JAMA. 1998
May 20;279(19):1571-3.
Mutru O, Penttila M, Pesonen J, et al. Diclofenac sodium (Voltaren) and
indomethacin in the ambulatory treatment of rheumatoid arthritis: a double-blind
multicentre study. Scand J Rheumatol Suppl. 1978;(22):51-6.
Nawrocki JW, Weiss SR, Davidson MH, et al. Reduction of LDL cholesterol
by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin,
a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol. 1995
May;15(5):678-82.
NCEP. Executive summary of the Third Report of the National Cholesterol
Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment
of High Blood Cholesterol in Adults. . JAMA. 2001;285(19):248697.
Ose L, Luurila O, Eriksson J, et al. Efficacy and safety of cerivastatin,
0.2 mg and 0.4 mg, in patients with primary hypercholesterolaemia: a multinational,
randomised, double-blind study. Cerivastatin Study Group. Curr Med Res
Opin. 1999;15(3):228-40.
Peters TK, Muratti EN, Mehra M. Efficacy and safety of fluvastatin in
women with primary hypercholesterolaemia
5. Drugs. 1994;47 Suppl 2:64-72.
Pharmacy Times. Top 10 drugs of 2001. Pharmacy Times.2002.Apr 68(4):105.
Preskorn SH. Pharmacokinetics of antidepressants: why and how they are
relevant to treatment. J Clin Psychiatry. 1993 Sep;54 Suppl:14-34.
Rainer MK, Masching AJ, Ertl MG, et al. Effect of risperidone on behavioral
and psychological symptoms and cognitive function in dementia. J Clin
Psychiatry. 2001 Nov;62(11):894-900.
Rakel RE. Conn's Current Therapy.1993.
Reuters Health. 57 deaths in Britain associated with Zyban. Reuters Health.
2002 Jan 1.
Reuters Health. Medical journals act to limit drug firms' influence. Reuters
Health. 2001 Sep 10.
Rickels K, Schweizer E, Clary C, et al. Nefazodone and imipramine in major
depression: a placebo-controlled trial. Br J Psychiatry. 1994 Jun;164(6):802-5.
Ridker PM, Rifai N, Rose L, et al. Comparison of C-reactive protein and
low-density lipoprotein cholesterol levels in the prediction of first
cardiovascular events. N Engl J Med. 2002 Nov 14;347(20):1557-65.
Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the
prescribing cascade. BMJ. 1997 Oct 25;315(7115):1096-9.
Rochon PA, Anderson GM, Tu JV, et al. Age- and gender-related use of low-dose
drug therapy: the need to manufacture low-dose therapy and evaluate the
minimum effective dose. J Am Geriatr Soc. 1999 Aug;47(8):954-9.
Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen
plus progestin in healthy postmenopausal women: principal results From
the Women's Health Initiative randomized controlled trial. JAMA. 2002
Jul 17;288(3):321-33.
Rowland MSLSJ. Variability in Drug Therapy: Description, Estimation, and
Control 1985 (A Sandoz Workshop). : .1985.
Roy D, Dawling S. Application of an individually predicted dosage of amitriptyline
to the treatment of depression. Int Clin Psychopharmacol. 1987 Oct;2(4):307-15.
Salkind MR, Silverstone T. A clinical and psychometric evaluation of flurazepam.
Br J Clin Pharmacol. 1975 Jun;2(3):223-6.
Salzman C. Practical considerations in the pharmacologic treatment of
depression and anxiety in the elderly. J Clin Psychiatry. 1990 Jan;51
Suppl:40-3.
Savarino V, Mela GS, Zentilin P, et al. Low bedtime doses of H2-receptor
antagonists for acute treatment of duodenal ulcer. Dig Dis Sci. 1989 Jul;34(7):1043-6.
Schatzberg AF, Dessain E, O'Neil P, et al. Recent studies on selective
serotonergic antidepressants: trazodone, fluoxetine, and fluvoxamine.
J Clin Psychopharmacol. 1987 Dec;7(6 Suppl):44S-9S.
Schatzberg AF. Dosing strategies for antidepressant agents. J Clin Psychiatry.
1991 May;52 Suppl:14-20.
Schulman KA, Seils DM, Timbie JW, et al. A national survey of provisions
in clinical-trial agreements between medical schools and industry sponsors.
N Engl J Med. 2002 Oct 24;347(17):1335-41.
Shapiro SSDK. The effects of ibuprofen in the treatment of dysmenorrhea.
Curr Ther Res. 1981;30(3):32734.
Sinatra S. Statins: grossly overprescribed for cholesterol and underprescribed
for internal inflammation. The Sinatra Health Report. 2002 Sep 1.
Sjoqvist F, Bertilsson L. Clinical pharmacology of antidepressant drugs:
pharmacogenetics. Adv Biochem Psychopharmacol. 1984;39:359-72.
Slatton ML, Irani WN, Hall SA, et al. Does digoxin provide additional
hemodynamic and autonomic benefit at higher doses in patients with mild
to moderate heart failure and normal sinus rhythm? J Am Coll Cardiol.
1997 May;29(6):1206-13.
Smith DL. DTC . DTC Perspectives. 2002.Jan.
Smucker WD, Kontak JR. Adverse drug reactions causing hospital admission
in an elderly population: experience with a decision algorithm. J Am Board
Fam Pract. 1990 Apr;3(2):105-9.
Snider S. The Pill: 30 Years of Safety Concerns.190.Dec.
Sparano N, Seaton TL. Troglitazone in type II diabetes mellitus. Pharmacotherapy.
1998 May;18(3):539-48.
Steinhagen-Thiessen E. Comparative efficacy and tolerability of 5 and
10 mg simvastatin and 10 mg pravastatin in moderate primary hypercholesterolemia.
Simvastatin Pravastatin European Study Group. Cardiology. 1994;85(3-4):244-54.
Thompson M, Bell D. Further experience with ibuprofen in the treatment
of arthritis. Rheumatol Phys Med. 1970;10:Suppl-3.
Tinkelman DFMBEea. Efficacy and safety of fexofenadine in fall seasonal
allergic rhinitis. J Allergy Clin Immunol. 1996;97(1):1009.
Tuomilehto J, Guimaraes AC, Kettner H, et al. Dose-response of simvastatin
in primary hypercholesterolemia. J Cardiovasc Pharmacol. 1994 Dec;24(6):941-9.
United States Pharmacopeia Drug Information (USP DI). Drug Information
for the Health Care Professional 1994.1994.
Vessey MP, Inman WH. Speculations about mortality trends from venous thromboembolic
disease in England and Wales and their relation to the pattern of oral
contraceptive usage. J Obstet Gynaecol Br Commonw. 1973 Jun;80(6):562-6.
Vollmann J. Gifts to physicians from the pharmaceutical industry. JAMA.
2000 May 24;283(20):2656-8.
Watkins PB, Whitcomb RW. Hepatic dysfunction associated with troglitazone.
N Engl J Med. 1998 Mar 26;338(13):916-7.
Weinstein L. Efficacy of a continuous estrogen-progestin regimen in the
menopausal patient. Obstet Gynecol. 1987 Jun;69(6):929-32.
Wernicke JF, Dunlop SR, Dornseif BE, et al. Low-dose fluoxetine therapy
for depression. Psychopharmacol Bull. 1988;24(1):183-8.
Wernicke JF, Dunlop SR, Dornseif BE, et al. Low-dose fluoxetine therapy
for depression. Psychopharmacol Bull. 1988;24(1):183-8.
Wierzbicki AS, Lumb PJ, Chik G, et al. High-density lipoprotein cholesterol
and triglyceride response with simvastatin versus atorvastatin in familial
hypercholesterolemia. Am J Cardiol. 2000 Sep 1;86(5):547-9, A9.
Williams RD. Medications and older adults. 997 SepOct:). FDA Consumer
Magazine. 1997.Sep31(6).
Williams RD. Medications and older adults. FDA Consumer Magazine. 1997.Sep.
Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal
antiinflammatory drugs. N Engl J Med. 1999 Jun 17;340(24):1888-99.
Wolfe SMHRE. Worst Pills, Best Pills II: The Older Adult's Guide to Avoiding
Drug-Induced Death or Illness.1993: .
Wolffenbuttel BH, Mahla G, Muller D, et al. Efficacy and safety of a new
cholesterol synthesis inhibitor, atorvastatin, in comparison with simvastatin
and pravastatin, in subjects with hypercholesterolemia. Neth J Med. 1998
Apr;52(4):131-7.
Wood AJ, Stein CM, Woosley R. Making medicines safer--the need for an
independent drug safety board. N Engl J Med. 1998 Dec 17;339(25):1851-4.
Young SA. Is academic medicine for sale? N Engl J Med. 2000 Aug 17;343(7):508-9.
Zuger A. Caution: that dose may be too high. New York Times.2004.Sep.17.
|